Abstract:BackgroundParkinson's disease (PD) is characterized by dopaminergic neuronal loss in the substantia nigra pars compacta and intracellular inclusions called Lewy bodies (LB). During the course of disease, misfolded α-synuclein, the major constituent of LB, spreads to different regions of the brain in a prion-like fashion, giving rise to successive non-motor and motor symptoms. Etiology is likely multifactorial, and involves interplay among aging, genetic susceptibility and environmental factors.Main bodyThe prevalence of PD rises exponentially with age, and aging is associated with impairment of cellular pathways which increases susceptibility of dopaminergic neurons to cell death. However, the majority of those over the age of 80 do not have PD, thus other factors in addition to aging are needed to cause disease. Discovery of neurotoxins which can result in parkinsonism led to efforts in identifying environmental factors which may influence PD risk. Nevertheless, the causality of most environmental factors is not conclusively established, and alternative explanations such as reverse causality and recall bias cannot be excluded. The lack of geographic clusters and conjugal cases also go against environmental toxins as a major cause of PD. Rare mutations as well as common variants in genes such as SNCA, LRRK2 and GBA are associated with risk of PD, but Mendelian causes collectively only account for 5% of PD and common polymorphisms are associated with small increase in PD risk. Heritability of PD has been estimated to be around 30%. Thus, aging, genetics and environmental factors each alone is rarely sufficient to cause PD for most patients.ConclusionPD is a multifactorial disorder involving interplay of aging, genetics and environmental factors. This has implications on the development of appropriate animal models of PD which take all these factors into account. Common converging pathways likely include mitochondrial dysfunction, impaired autophagy, oxidative stress and neuroinflammation, which are associated with the accumulation and spread of misfolded α-synuclein and neurodegeneration. Understanding the mechanisms involved in the initiation and progression of PD may lead to potential therapeutic targets to prevent PD or modify its course.

Epidemiology of Parkinson’s disease

The epidemiology of Parkinson's disease

Epidemiology and etiology of Parkinson’s disease: a review of the evidence

Update: Descriptive epidemiology of Parkinson disease

Parkinson's Disease and the Environment

Epidemiology of Parkinson's Disease: An Update

Environmental Factors in Parkinson's Disease: New Insights into the Molecular Mechanisms.

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease

A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population

The gastrointestinal tract and Parkinson's disease

Incidence of Parkinson disease in North America

Parkinson's Disease is Predominantly a Genetic Disease

Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder

1851 Increasing number of deaths related to Parkinson’s disease (PD) and Parkinsonism

Exercise-Induced Autophagy and Parkinson’s Disease

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics

Update: Protective and Risk Factors for Parkinson Disease

Gene–environment Interactions: Key to Unraveling the Mystery of Parkinson's Disease

Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications

Parkinson’s disease: etiopathogenesis and treatment

Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors